We critically evaluated the role of the adenosine A 1 receptor (A 1 R) in normal development of retinal vasculature and pathogenesis of retinopathy of prematurity (ROP) by using the A 1 R knockout (KO) mice and oxygen-induced retinopathy (OIR) model.
R etinopathy of prematurity is the most common cause of blindness in childhood. 1 This sight-threatening disease is characterized by two critical phases, hyperoxia-and inflammation-induced damage to retinal vessels and vaso-obliteration followed by hypoxia-driven physiological revascularization and pathologic neovascularization, the processes largely driven by hypoxia-induced factor-1a (HIF-1a) signaling pathway and vascular endothelial growth factor (VEGF) levels in retina. 1, 2 Conventional therapies for ROP are limited to laser and cryosurgery, which ablate the avascular retina to prevent retinal detachment caused by ROP. 3 However, the effects of ablative laser therapy are limited and are associated with destruction to retina, causing clinically significant loss of visual field. Anti-VEGF therapy (e.g., intravitreal injection of anti-VEGF-A antibody bevacizumab) has been proposed 3 and has recently been tested in a randomized, controlled, and multicenter trial involving 150 infants, which showed reduction of the recurrence rate, 4 but the efficacy of intravitreal bevacizumab remains unclear with reported persistent avascular retina 5 and recurrent intravitreal neovascularization. 6 Importantly, VEGF acts not only as an angiogenic factor, but also as a neurotrophic factor during retinal development. Thus, there are concerns on the unintended effects of anti-VEGF agents on delayed growth and retinal vasculature development of preterm infants.
increases in extracellular adenosine production (up to 100-fold) and signaling events through the markedly induced adenosine receptors (up to 50-fold) locally. 10 For example, in a canine model of ROP, the expression of 5 0 nucleotidase (CD73, an enzyme responsible for generating extracellular adenosine) and adenosine A 2A receptor (A 2A R) was suppressed during the hyperoxic phase, but markedly increased in hypoxic retina, supporting the possible involvement of adenosine-A 2A R signaling in retinal pathologic angiogenesis. [11] [12] [13] [14] Increased adenosine-adenosine receptor signaling in hypoxic retina not only constitutes a defense mechanism to protect retina by modulating neuroinflammation, cell death, and promoting angiogenesis, but also offers an opportunity of targeting pathologic angiogenesis of ROP with minimal effects on normal retinal vascular development. In support of this view, we have recently demonstrated that genetic inactivation of the A 2A R attenuated hypoxia-induced pathologic angiogenesis without affecting normal postnatal retinal vascularization. 15 Therapeutic potential of adenosine receptor-based therapy for ROP is supported by the ability of adenosine receptors to modulate inflammation, neuroprotection, and angiogenesis in retina through activation of four G-protein-coupled receptors, namely, A 1 , A 2A , A 2B , and A 3 , all of which have been detected in retina. 16, 17 Increased adenosine acting at A 2A Rs suppresses neuroinflammation and protects against diabetic retinopathy (DR) 18 and traumatic optic neuropathy, 19 through control of retinal microglial function and production of proinflammatory cytokines 20, 21 ; studies with genetic inactivation of the A 2A R, 15 with A 2B R antagonists [22] [23] [24] and with ribozyme approach to inactivating A 2B Rs, demonstrate that adenosine acting at the A 2A and A 2B receptors promotes pathologic angiogenesis in retina through modulating VEGF level. 25 The translational potential of adenosine receptor-based therapy for controlling proliferative retinopathy is substantiated by a clinical potential, since a recent large clinical trial of 2006 infants has demonstrated that treatment with caffeine, a nonselective adenosine receptor antagonist, reduces ROP-related problems after 2-year follow-up, 26 and by genetic identification of the variants of the human A 2A R gene that are associated with reduced risk of developing DR in a prospective study. 27 Several studies of adenosine receptor control of retinal vascularization have focused on the A 2A R effect, 11, 15, 18 with some on the A 2B receptor. 25 Adenosine A 1 receptor (A 1 R) mRNA and ligand binding are detected in developing retina. 17 However, the A 1 R effect on retinal vascularization is largely unknown. As an important step in developing adenosine receptor-based treatment for ROP, we critically evaluated the role of the A 1 R in normal development of retinal vasculature and pathogenesis of proliferative retinopathy by using the A 1 R knockout (KO) mice and oxygen-induced retinopathy (OIR) model. Our characterization of the A 1 R KO and wild-type (WT) mice in normal and OIR model demonstrated for the first time that A 1 R activity did not affect normal retinal vascular development, but distinctly controlled hyperoxiainduced vaso-obliteration at P12 and hypoxia-induced revascularization at P17 by acting at A 1 Rs in distinct cellular elements. ), heterozygous A 1 R KO (A 1 R À/þ ), and WT littermates (A 1 R þ/þ ). The mouse genotype was determined by PCR analysis of genomic DNA extracted from mouse tails. Genetic deletion of the A 1 R did not affect normal development and most physiological measurements including the body weight, heart rate, blood pressure and body temperature 28 and survival rate in this study.
MATERIALS AND METHODS

Congenic
Mouse Model of Oxygen-Induced Retinopathy
The mouse model of OIR was performed according to the protocol as previously described by Smith and colleagues. 29 Briefly, pups with their dams were kept in a 75% 6 2% oxygen chamber for 5 days from postnatal day (P) 7 to P12. Nursing mothers were prepared to replace dams for feeding pups every 12 hours during the hyperoxic stage (P7-P12). At P12, the animals were returned to room air for 5 days (from P12 to P17). Age-matched mice raised in room air (P0-P17) were used as the ''room air'' control group for study of normal postnatal development retinal vascularization.
Fluorescence Immunostaining in Whole-Mount Retinas
Fluorescence staining of whole-mounted retinas was performed as previously described. 30 Eyes were fixed in 4% paraformaldehyde and the retinas were dissected and stained with 10 lg/mL isolectin B4 (Molecular Probes, Life Technologies, Carlsbad, CA, USA) after being blocked and permeabilized. The retinas were then incubated with anti-glial fibrillary acidic protein (GFAP) mouse monoclonal antibody (1:500; Sigma-Aldrich Corp., St. Louis, MO, USA) for 12 hours at 48C, followed by incubation with fluorescence-conjugated second antibody (1:500; Invitrogen, Life Technologies) for 2 hours, and then whole-mounted. Eight nonoverlapping and randomly selected microscopic fields per retina were imaged by confocal scanning laser microscopy (LSM 710; Carl Zeiss, Oberkochen, Germany) to assess the formation of endothelial tip cells.
To assess normal postnatal development of retinal angiogenesis, A 1 R KO pups and WT littermates (breeding in room air) were killed and the eyes were harvested at P3, P5, P7, P12, and P17. Whole-mount retinas were stained with isolectin B4. The development of superficial vascular layer from P0 to P7 was quantified as the ratio of vascular area to total retinal area. Three nonoverlapping and randomly selected microscopic fields per retina and whole-mounted retina were assessed for morphology and distribution of retinal vessels from P7 to P17.
Neovascular Nuclei Quantification
To quantify neovascular nuclei, eyes were fixed in 4% paraformaldehyde, embedded in paraffin, sectioned (5 lm), and stained with hematoxylin-eosin. The nuclei beyond the internal limiting membrane on the vitreous side were defined as neovascular nuclei and counted by an investigator in a blinded manner.
TUNEL Staining for Detection of Cell Apoptosis
The TUNEL staining was performed by using a commercial in situ cell death detection kit and following the procedure of the manufacturer's manual (Roche Diagnostics, Basel, Switzerland). The TUNEL-positive cells were counted from three sections crossing the optic nerve per retina to quantify the change of TUNEL signal.
Immunofluorescence Analysis
At P17, mouse eyes were dissected and embedded in paraffin. After being deparaffinized and heated in 10 mM sodium citrate for antigen repairing, retinal paraffin sections were blocked and permeabilized and then were incubated with antiproliferating cell nuclear antigen (PCNA) rabbit polyclonal antibody (1:200; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-GFAP mouse monoclonal antibody (1:500; SigmaAldrich Corp.), or anti-Iba-1 rabbit monoclonal antibody (Wako, Chuo-ku, Osaka, Japan) overnight at 48C. Fluorescence-conjugated second antibodies (1:500; Invitrogen, Life Technologies) were applied to detect the positive signals. The GFAP/PCNA-positive cells were counted from three sections crossing the optic nerve per retina.
Quantitative Analysis of A 1 R mRNA Levels Adenosine A 1 receptor mRNA level in retina harvested at P17 was done by the quantitative real-time polymerase chain reaction (qPCR) procedure as we have described previously 15 using the following forward and reverse primers for A 1 R mRNA: 5 0 -CATCCTGGCTCTGCTTGCTATT-3 0 and 5 0 -TTGGCTATCCAGGCTTGTTCC-3.
0
Statistical Analysis
All data were expressed as mean 6 SEM. Statistical analyses were conducted by using Student's t-test, with P < 0.05 being considered statistically significant.
RESULTS
Genetic Deletion of the A 1 R Did Not Affect the Normal Development of Retinal Vascularization in Mice
To determine the effect of A 1 R gene deletion on normal development of retinal vascularization, we analyzed development of the retinal vascular networks at P3, P7, P12, and P17 of homozygous
) littermates by fluorescein staining of whole-mounted retinas (Fig. 1A) . At P3, the vessels grew radially from the optic nerve head toward the edge of the retina and became progressively interconnected and formed an initial superficial vascular layer. At P5, the deep vascular layer was apparent under the superficial layer, and the vasculature of both WT and A 1 R KO mice covered approximately half of the entire retinal area (data not shown). At P7, the average vascular area ratio of the WT and A 1 R KO group was 78% and 79%, respectively. At P12, the vasculature covered all the retina for WT and A 1 R KO mice, and an intermediate vascular layer developed between the superficial and deep layer. Quantitative analysis revealed that the vascular area at P3 (n ¼ 3/group) and P7 (n ¼ 3/group) was comparable between WT and A 1 R KO mice (Fig. 1A) . At P12 and P17, retinal vascularization was near complete and the arborous pattern of retinal vasculature formed over the entire retina with very few avascular areas. Thus, we adapted ''branch point'' analysis 31 for quantification of retinal vascularization at P12 and P17. Importantly, branch point analysis showed that retinal vascularization was indistinguishable between WT and A 1 R KO mice at P12 (n ¼ 6/group) and P17 (n ¼ 8/group), indicating that the superficial retinal vasculature grew with similar rates with indistinguishable patterns of the vessel distribution between WT and A 1 R KO mice. Moreover, distinct morphologies of three vessel layers were also observed under the confocal scanning laser microscopy at P12 and P17 (Fig. 1B) . Arterioles in the superficial layer had numerous dichotomous branches. The vessels in the intermediate layer presented short capillary segments. The vessels in the deep layer formed anastomotic grids. Similarly, the morphology and distribution of retinal blood vessels were indistinguishable between WT and A 1 R KO mice.
Collectively, quantitative analysis of retinal vascularization under room air with total 20 WT and 20 A 1 R KO mice at different stages (P3, P7, P12, and P17) demonstrates that A 1 R activity is not required for normal postnatal development of retinal vascularization in mice.
Genetic Deletion of A 1 Rs Reduced HyperoxiaInduced Retinal Vascular Regression and Cellular Apoptosis at P12
As the first evidence for the involvement of A 1 R in OIR, we found that A 1 R mRNA in retina of OIR harvested at P17 was markedly reduced compared to the room air condition (n ¼ 8, P < 0.01) (Fig. 2) . This reduction of A 1 R mRNA may reflect the reduced protective effect by adenosine acting at A 1 Rs in retina.
To assess the effect of A 1 R gene deletion at the hyperoxic stage of OIR, we analyzed the vascular regression of WT and A 1 R KO mice in whole-mounted retinas with isolectin B4 staining. Both WT and KO groups clearly revealed large areas of vaso-obliteration in the central retina (Fig. 3A) . Quantitative analysis of retinal vaso-obliteration showed that the percentage of avascular areas of total retina in the A 1 R KO group was significantly smaller than that of the WT group by~20% (6.64% absolute difference over 33.23% of total avascular area ¼~20%) (Fig. 3B ), indicating that A 1 R activation increased hyperoxia-induced retinal vaso-obliteration.
Vaso-obliteration in OIR is a result of neuronal and endothelial apoptosis induced by a combination of direct toxicity of reactive oxygen species to neurons and a downregulation of HIF-1a-dependent VEGF expression to endothelial cells. 32 We performed TUNEL analysis to determine whether the larger avascular region in WT mice at P12 was attributed to neuronal and endothelial apoptosis. Consistent with other studies, [33] [34] [35] TUNEL-positive signals were detected within the inner nuclear layer (INL; mainly neurons such as amacrine cells and bipolar cells) and outer nuclear layer (ONL) of the avascular area, as well as the ganglion cell layer (GCL) of both WT and A 1 R KO groups. Furthermore, TUNEL signal was detected in both INL and ONL layers but largely segregated from the CD31 þ cells (a marker for endothelium cells) with only very few TUNEL/CD31 costaining signals, indicating that apoptosis was mainly attributed to neuronal apoptosis in retina (Figs. 3C, 3D ). Quantitative analysis showed that TUNELpositive cells were significantly higher in WT mice than A 1 R KO mice at P12 (Fig. 3E) . Thus, A 1 R gene deletion reduces avascular areas at least partly by reducing hyperoxia-induced neuronal apoptosis in retina.
Genetic Deletion of A 1 Rs Attenuated HypoxiaInduced Intraretinal Revascularization but Not Intravitreal Neovascularization at P17
In contrast to the reduced avascular area of A 1 R KO mice at P12, quantitative analysis revealed that the A 1 R KO mice in fact had increased avascular area, compared to WT group, at P17 (Figs. 4A, 4B ). This increased avascular area in A 1 R KO mice at P17 could likely be attributed to a perturbation of revascularization in A 1 R KO mice at the hypoxic phase. We also investigated the effect of A 1 R KO on pathologic angiogenesis and showed that there was no significant difference in neovascularization tufts toward the vitreous and neovascular nuclei that formed at the hypoxia phase between A 1 R KO and WT groups (Figs. 4A-D) . Furthermore, we also analyzed the expression of PCNA, an indicator of cell proliferation, in retina at P17. Consistent with earlier studies, 15, 36 we detected PCNApositive signals mainly in the superficial vasculature and neovascular tufts surrounding the lumen in the GCL of WT and A 1 R KO mice (Fig. 4E) . However, the numbers of PCNApositive cells were indistinguishable between A 1 R KO and WT mice at P17, consistent with the lack of A 1 R KO on neovascularization tufts (Fig. 4F) . Additional analysis showed that scatter TUNEL-positive cells were detected in retina (mainly in the inner and outer nuclear layer) and largely segregated from CD31 þ cells (Figs. 4G, 4H ). There was no difference in retinal TUNEL-positive cells between WT and A 1 R KO groups, indicating that the reduced revascularization was not due to increased apoptosis (Fig. 4I) . These results showed that at the hypoxic phase, A 1 R activation promoted intraretinal revascularization without affecting intravitreal neovascularization, an effect not being attributed to cellular apoptosis or endothelial cellular proliferation in retina.
Genetic Deletion of the A 1 R Did Not Affect the Number of Microglial Cells and Astrocytes but Reduced the Formation of Endothelial Tip Cells to Attenuate Intraretinal Revascularization in Hypoxia Phase
We further sought to identify the cellular mechanisms underlying the effects of A 1 R activation on promoting revascularization by analyzing function of microglial cells, astrocytes, and endothelial tip cells in retina of WT and A 1 R KO mice at P17 of OIR.
Immunohistochemistry analysis of Iba-1 expression in retina showed that microglial activation in retina (mainly in the GCL and INL layers) was indistinguishable between A 1 R KO and WT littermates (Figs. 5A , 5B). Thus, inflammatory response (as indirectly indicated by microglial activation) is unlikely a major contributing factor in A 1 R control of retinal vascularization and retinopathy. Furthermore, retinal astrocytes participate in angiogenesis in response to hypoxia through their high expression of VEGF 37 and their support for the growth of the leading edge of the developing superficial vascular network. 38, 39 Consistent with previous studies, 40 GFAP-positive cells were mainly detected in the GCL of retina by immunofluorescence staining. However, GFAP-positive astrocytes in retina were not significantly affected by the genetic inactivation of A 1 R (Figs. 5C, 5D ). Endothelial tip cells play an important role during angiogenesis by sensing the VEGF gradient produced by astrocytes and by leading the extension of typical filopodia in retinal sprout tips. We therefore further evaluated the formation of endothelial tip cells in retina of WT and A 1 R KO groups at P17 of OIR. As seen in Figures 5E and 5F , tip cell filopodia adhered to GFAP-positive astrocytes. Quantitative analysis revealed that the number of endothelial tip cells in retina was significantly reduced in A 1 R KO group compared with WT group (Fig. 5G ). This finding suggests that A 1 R activation enhanced function of endothelial tip cells to promote hypoxia-induced revascularization in retina at P17 of OIR.
Lastly, we analyzed avascular area of A 1 R KO and WT littermates of OIR at P21. In contrast to the A 1 R KO effect at P17, the avascular area in retina was in fact smaller in A 1 R KO than in their WT littermates (Figs. 6A, 6B; n ¼ 7 per group), indicating that A 1 R activation at the P17 to P21 period apparently slows down normal vascularization of retina in OIR model. Thus, A 1 R inactivation exerted distinct effects on retinal vascularization at P12, P17, and P21, likely depending on the different levels of adenosine and different cellular populations involved in these different stages of OIR.
DISCUSSION Adenosine A 1 Receptor Activity Selectively Modulates Oxygen-Induced Retinopathy Without Affecting Normal Retinal Vascular Development
One of the critical concerns in developing therapeutic strategy for treating ROP is to achieve maximal therapeutic effect on proliferative retinopathy with minimal unintended side effects on neurovascular development in retina. In agreement with our previous finding that A 2A R inactivation selectively modulates pathologic angiogenesis without affecting normal retinal vasculature development, 15 genetic deletion of A 1 R activity preferentially affected retinal vascularization under pathologic condition of OIR, but postnatal retinal vascularization developed normally with typical morphology, density, and distribution of retinal vessels from P3 to P17 in the absence of the A 1 R (Fig. 1) . This finding reinforces our contention that interruption of adenosine signaling through A 1 R and A 2A R has no effect on normal retinal vascular development. This selectivity is further supported by the finding that A 1 R mRNA was reduced in retina of OIR model compared to that of room air at P17. The finding confers a critical advantage for the proposed adenosine receptor-based therapeutic strategy over other treatment strategies (such as anti-VEGF antibody), since activity of these molecular targets may be necessary not only for pathologic angiogenesis, but also for normal retinal vascularization during development. 41 This A 1 R and A 2A R selective control of pathologic retinal vasculature growth in OIR may be in part attributed to the surge of extracellular adenosine and the marked induction of adenosine receptors in response to hypoxia. 10 In models of KO in room air were examined by isolectin B4 staining of whole-mount retinas. The development of morphology and distribution of superficial, intermediate, and deep plexuses were indistinguishable between WT and A 1 R KO mice. Scale bar: 50 lm. Figure 2 . Adenosine A 1 receptor mRNA level was reduced in retina of OIR compared to that of room air at P17. Retina of OIR and room air was dissected and harvested at P17, and A 1 R mRNA expression in retina was determined by qPCR analysis. Compared to the room air group, A 1 R mRNA in retina of OIR was markedly reduced (Fig. 2 , n ¼ 8/ group). Data are presented as the mean 6 SEM. *P < 0.05, Student's ttest.
ROP, hypoxia triggers the surge in extracellular adenosine as a result of transcriptional induction of CD73 and equivalent nucleotide transporter 1 as well as suppression of adenosine kinase, thereby elevating the capacity of local tissues for extracellular adenosine production. 11, 42 Adenosine accumulating locally during hypoxia permits the local control of retinal vessel growth. 11 Furthermore, pathologic conditions are accompanied by the increases of local inflammatory The avascular area (%) was quantified as the ratio of central avascular area to whole retinal area. The neovascularization tufts area (%) was quantified as a percentage of whole retinal area. (C) Retinal pathologic angiogenesis at P17 was observed by using hematoxylin and eosin staining (n ¼ 7 cytokines such as interleukin-1b (IL-1b) and tumor necrosis factor-a, which lead to a delayed (~24 hours), marked, and sustained increase in adenosine receptor (particularly A 2A R and the A 2B R) expression in tissues and inflammatory cells. [43] [44] [45] Locally increased adenosine levels and adenosine receptor signaling might represent a local ''find-me'' signal and service a unique ''purinergic chemotaxis'' for a local resolution to pathologic conditions (as revealed by genetic KO studies). 10 Thus, the surge of adenosine level and the induction of adenosine receptors in the hypoxic phase of OIR 11 may constitute a negative feedback and defense mechanism countering such proangiogenic states triggered by hypoxia and HIF-1a-mediated expression of VEGF in retina. Further dissection of the A 1 R and A 2A R signaling interacting with the molecular and cellular pathways, leading to distinct physiological development and pathologic angiogenesis, is needed to fully understand this selectivity of A 1 R and A 2A R control of OIR.
Adenosine A 1 Receptor Inactivation Reduces Hyperoxia-Induced Vaso-obliteration by Attenuating Neural Apoptosis in Retina at P12
A hallmark of ROP is abnormal and excessive blood vessel growth, but paradoxically it is early vaso-obliteration that initiates proliferative retinopathy. Thus, preventing early retinal vessel loss at the hyperoxic phase can prevent the devastating latter stage (the hypoxic phase) of the disease. In the vasoobliteration phase, hyperoxia induces apoptosis of ganglia and developing endothelial cells and inhibits endothelial cell proliferation and migration, resulting in vaso-obliteration. 32, 46 Notably, despite clear vaso-obliteration at the retina center in the hyperoxic phase, there is no ''hypoxia'' in retina as shown by in vivo detection with nitroimidazole EF5. 47 Since the adenosine concentration and the expression of ecto-5 0 nucleotidase (CD73) are low during the hyperoxic phase, we presumed that A 1 Rs play a limited role at this stage. Surprisingly, we found that the avascular area and TUNELpositive cells in the INL of retina in A 1 R KO mice were reduced as compared to WT littermates, suggesting that A 1 R activation probably aggravated hyperoxia-induced damage to developing retinal vessels by affecting neuronal apoptosis. Activation of retinal A 1 Rs has been shown to inhibit Ca2þ channels in retinal ganglion cells of mini-slices, 48, 49 to protect NMDA-induced cell death in cultured retinal neurons, 50 and to mediate the IL-6 effect on the survival of cultured retinal ganglion cells. 51 Consistent with the A 1 R-mediated neuroprotective effect, early studies 28, 52, 53 indicate that cytotoxicity and cell death are generally more pronounced in neurons and astrocytes derived from A 1 R KO mice. Thus, additional studies are clearly warranted to clarify how A 1 R KO may confer cellular protection at the hyperoxic phase of OIR. Nonetheless, our findings highlight for the first time the important function of adenosine-A 1 Rs in modulating retinal vascular function even under hyperoxic environments with low extracellular adenosine level.
Adenosine A 1 Receptor Activation Is Required for Hypoxia-Driven Physiological Revascularization, but Not Neovascularization in Retina at P17
In the vaso-proliferation phase of OIR, both regrowth of normal (intraretinal) revascularization and pathologic (intravitreal) angiogenesis occur during P12 to P17, the former promoting retinal vascular recovery but the latter resulting in pathologic neovascularization tufts. Current research on ROP has been largely focused on the mechanism that drives pathologic (intravitreal) neovascularization in the retina and treatment strategies to stop it. 1, 2, 4, 9 On the other hand, intraretinal revascularization has received much less attention. 54 An early study 55 has reported that the A 1 R agonist CPA increases membrane vessel in the chick chorioallantoic membrane model. This study provides the first in vivo demonstration that A 1 R activation is critical to beneficial intraretinal revascularization at the hypoxic phase by showing that A 1 R inactivation increases the avascular area without changes in neovascularization.
Control of retinal vascularization during development and OIR likely involves close interactions among neurons, astrocytes, microglial cells, and endothelial cells. Impairment in beneficial intraretinal revascularization by genetic deletion of the A 1 R can be attributed to several factors such as reduced endothelial cell proliferation, increased intravitreal neovascularization, and increased cell apoptosis, leading to reduced astrocytic functions or reduced tip cell formation. Despite the fact that ROP is fundamentally a vascular proliferating disorder, our findings suggest that cell proliferation and vitreal neovascularization tufts are apparently not important factors for A 1 R control of intraretinal revascularization. Moreover, control of avascular area in A 1 R KO mice is also not associated with cellular apoptosis, since the numbers of TUNEL-positive cells at P17 were comparable between WT and A 1 R KO groups. Similarly, retinal inflammatory response is unlikely a major contributing factor in A 1 R control of retinal vascularization and retinopathy, since microglial activation was not affected by A 1 R inactivation. Astrocytes play a significant role in angiogenesis in response to hypoxia through their high expression of VEGF. 37 Indeed, studies in OIR models have shown that the density of astrocytes in the retina decreases during hyperoxia and then increases following hypoxia, 56, 57 and that restoring retinal astrocytes reduces vascular pathology associated with OIR. 40, 58 However, our analysis revealed that the GFAP-positive cells (astrocytes) in retina at P17 were indistinguishable between WT and A 1 R KO mice. Thus, under our experimental condition, cell types other than astrocytes are likely responsible for the A 1 R-mediated modulation of hypoxia-induced intraretinal vascularization.
At the tips of vascular sprouts with long filopodia are endothelial tip cells that play an important role in developmental blood vessel formation and physiological revascularization. 59 In retina, endothelial tip cells are mainly located at the leading edge of vascular plexus and the fusion sites of the remodeling area. 60 In sprouting angiogenesis, though, the filopodia of endothelial tip cells participate in intercellular communication, cell migration, and cell adhesion to lead the retinas from 7 WT mice and n ¼ 7 retinas from 12 A 1 R KO mice). Nuclei on the vitreal side of the inner limiting membrane are indicated by black in (B, D, F, I ) are presented as mean 6 SEM. ***P < 0.001 (Student's t-test), comparing A 1 R KO group with WT group. outgrowth of blood vessels toward the gradients of VEGF-A. 61 Consistent with this functional view of tip cells, we detected filopodia of endothelial tip cells that were closely attached to the astrocytes in retina. Importantly, our analysis revealed that the quantity of endothelial tip cells is reduced by genetic deletion of the A 1 R at P17. Thus, activation of A 1 Rs promotes revascularization by increasing the number of endothelial tip cells, with normal morphology of filopodia to ensure vascular extension in the right direction along the astrocyte template. Whether the A 1 R control of tip cells is achieved by a direct effect of A 1 Rs in tip cells or an indirect effect of A 1 Rs in neurons (by stimulating platelet derived growth factor) or astrocytes (by releasing VEGF) on tip cells needs to be clarified in future studies. Moreover, future studies of A 1 R control of expression of the tip cell-specific candidate genes that are significantly upregulated in the tip cell fraction of sprouting vessels in a mouse model of OIR 62 would shed light on the transcriptional mechanism underlying A 1 R control of tip cells in promoting retinal vascularization.
Adenosine A 1 Receptor Inactivation Promotes
Retinal Normal Vascularization at P21 of OIR As further demonstration of the stage-specific effect of A 1 R inactivation, we uncovered that A 1 R activation at the P17 to P21 period apparently slows down retinal vascularization in OIR model. This new level of complexity of A 1 R activity reinforces the notion that adenosine acting at A 1 Rs exerts distinct functions at different courses of the disease (P12, P17, and P21). Distinct effects of A 1 R KO at P12, P17, and P21 may be due to the different levels of adenosine and different cellular populations involved in these different processes. Consequently, adenosine-based therapeutic strategy should be diseasestage-specific.
In summary, the findings that A 1 Rs (this study) and A 2A Rs 15 selectively modulate OIR without affecting normal retinal vascular development confer a critical advantage for the proposed adenosine receptor-based therapeutic strategy over other treatment strategies (such as anti-VEGF antibody) that also compromise normal retinal vasculature during development. We uncovered distinct A 1 R control of hyperoxia-induced vaso-obliteration at P12 and hypoxia-induced revascularization at P17 by acting on neurons and tip cells. These findings advance the prospective of adenosine receptor-based therapy for ROP with two novel strategies: (1) to reduce hyperoxiainduced retinal vessel loss (with A 1 R antagonists) to effectively control OIR, rather than direct inhibition of pathologic (intravitreal) neovascularization; and (2) to promote intraretinal revascularization (with A 1 R agonists) at the hypoxic phase, thus shifting from blocking pathologic intravitreal neovascularization toward beneficial intraretinal revascularization. From the translational perspective, it would be interesting to study the genetic association between the single nucleotide polymorphism of the human genes encoding the A 1 receptor (AdoraA1) and ROP, as revealed in other pathologic conditions such as apnea of prematurity, 63 ischemic cardiomyopathy, 64 and development of posttraumatic seizures. 65 Lastly, the demonstration of the distinct and coordinated control of OIR by retinal A 1 Rs and A 2A Rs also provides biological basis for the clinical finding that the use of caffeine (the nonselective A 1 R and A 2A R antagonist) in treatment of apnea in premature infants is associated with reduced ROP in a 2-year follow-up study.
